Skip to main content
. 2016 Jul 18;28(2):632–644. doi: 10.1681/ASN.2016020126

Table 3.

Frequency of secondary outcomes (cause of death, cause of allograft failure, and early complications), by cause of ESRD, n=107,778

Outcome Primary GN subtypes Secondary GN subtypes Non-GN Comparator Groups
FSGS n=13,272 IgAN n=7379 MN n=2249 MPGN n=1980 LN n=5884 Vasculitis n=1367 DN n=57,190 ADPKD n=18,457
Causes of death, n (%)
 Cardiovascular 641 (4.8) 154 (2.1) 146 (6.5) 113 (5.7) 308 (5.2) 46 (3.4) 6431 (11.2) 742 (4.0)
 Infection 241 (1.8) 63 (0.9) 43 (1.9) 42 (2.1) 133 (2.3) 34 (2.5) 2157 (3.8) 297 (1.6)
 Malignancy 165 (1.2) 62 (0.8) 47 (2.1) 32 (1.6) 49 (0.8) 24 (1.8) 847 (1.5) 290 (1.6)
 Other 546 (4.1) 154 (2.1) 115 (5.1) 104 (5.3) 256 (4.4) 78 (5.7) 5085 (8.9) 776 (4.2)
 Missing cause 539 (4.1) 135 (1.8) 112 (5.0) 99 (5.0) 207 (3.5) 79 (5.8) 6111 (10.7) 818 (4.4)
 Patient still alive at last follow-up 11,141 (83.9) 6811 (92.3) 1786 (79.4) 1590 (80.3) 4932 (83.8) 1106 (80.9) 36,559 (63.9) 15,534 (84.2)
Causes of allograft failure, n (%)
 Primary nonfunction 178 (1.3) 44 (0.6) 20 (0.9) 22 (1.1) 59 (1.0) <10 (<1%) 643 (1.0) 142 (0.8)
 Graft thrombosis 148 (1.1) 66 (0.9) 21 (0.9) 18 (0.9) 67 (1.1) 17 (1.2) 505 (0.9) 196 (1.1)
 Acute rejection 430 (3.2) 156 (2.1) 54 (2.4) 53 (2.7) 244 (4.1) 28 (2.1) 1231 (2.2) 284 (1.5)
 Chronic rejection 973 (7.3) 363 (4.9) 172 (7.6) 170 (8.6) 514 (8.7) 75 (5.5) 3226 (5.1) 756 (4.1)
 Infection 94 (0.7) 32 (0.4) 25 (1.1) 16 (0.8) 38 (0.7) <10 (<1%) 528 (0.8) 128 (0.7)
 Recurrent GN 355 (2.7) 121 (1.6) 75 (3.3) 110 (5.6) 67 (1.1) <10 (<1%) 253 (0.4) 57 (0.3)
 Other 509 (3.8) 176 (2.4) 82 (3.6) 111 (5.6) 241 (4.1) 39 (2.9) 1854 (3.2) 440 (2.4)
 Death 1204 (9.1) 343 (4.7) 267 (11.9) 190 (9.6) 472 (8.0) 171 (12.5) 14,124 (24.7) 2036 (11.0)
 Missing cause 464 (3.5) 180 (2.4) 68 (3.0) 83 (4.2) 197 (3.4) 20 (1.5) 2732 (4.8) 310 (1.7)
 Graft functioning at last follow-up 8921 (67.2) 5902 (79.9) 1466 (65.1) 1207 (61.0) 3988 (67.7) 994 (72.7) 32,094 (56.1) 14,108 (76.4)
Early post-transplant complications, n (%)
 DGF 2032 (15.3) 662 (9.0) 329 (14.6) 267 (13.5) 751 (12.8) 163 (11.9) 11,222 (19.6) 2230 (12.1)
 Missing 52 (0.4) 27 (0.4) 12 (0.5) 17 (0.9) 36 (0.6) <10 (<0.5) 299 (0.5) 66 (0.4)
 Oliguria 1056 (8.0) 385 (5.2) 164 (7.3) 133 (6.7) 400 (6.8) 84 (6.1) 5476 (9.6) 1196 (6.5)
 Missing 2847 (21.5) 1531 (20.8) 543 (24.1) 518 (26.2) 1299 (22.1) 285 (20.9) 13,712 (24.0) 4240 (23.0)
 Acute rejection 237 (1.8) 122 (1.7) 32 (1.4) 31 (1.6) 112 (1.9) 21 (1.5) 895 (1.6) 219 (1.2)
 Missing 5930 (44.7) 3057 (41.4) 1138 (50.6) 1040 (52.5) 2689 (45.7) 563 (41.2) 28,150(49.2) 8346 (45.2)

DN, diabetic nephropathy.